Ad is loading...
IEMLX
Price
$9.88
Change
-$0.01 (-0.10%)
Updated
Nov 15 closing price
RNWEX
Price
$79.58
Change
-$0.79 (-0.98%)
Updated
Nov 15 closing price
Ad is loading...

IEMLX vs RNWEX

Header iconIEMLX vs RNWEX Comparison
Open Charts IEMLX vs RNWEXBanner chart's image
Voya Multi-Manager Emerging Markets Eq W
Price$9.88
Change-$0.01 (-0.10%)
VolumeN/A
CapitalizationN/A
American Funds New World R4
Price$79.58
Change-$0.79 (-0.98%)
VolumeN/A
CapitalizationN/A
IEMLX vs RNWEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IEMLX vs. RNWEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IEMLX is a Sell and RNWEX is a Buy.

FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 60.9B vs. IEMLX (197M). IEMLX pays higher dividends than RNWEX: IEMLX (1.77) vs RNWEX (1.24). IEMLX was incepted earlier than RNWEX: IEMLX (13 years) vs RNWEX (22 years). IEMLX is a more actively managed with annual turnover of: 85.00 vs. RNWEX (32.00). RNWEX has a lower initial minimum investment than IEMLX: RNWEX (250) vs IEMLX (1000). RNWEX annual gain was more profitable for investors over the last year : 11.20 vs. IEMLX (8.66). RNWEX return over 5 years is better than : 16.22 vs. IEMLX (-12.16).
IEMLXRNWEXIEMLX / RNWEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years22 years-
Gain YTD2.4906.81937%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets197M60.9B0%
Annual Yield % from dividends1.771.24142%
Returns for 1 year8.6611.2077%
Returns for 3 years-26.88-15.12178%
Returns for 5 years-12.1616.22-75%
Returns for 10 years1.2939.203%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVC2.57-0.01
-0.39%
Entravision Communication
DPZ430.43-5.54
-1.27%
Domino's Pizza
KPRX3.29-0.11
-3.15%
Kiora Pharmaceuticals Inc.
FORM37.80-1.89
-4.76%
FormFactor
PRTA14.01-2.09
-12.98%
Prothena Corp